Author: GlobeNewswire

Biosimulation software and services fuel second quarter growthPRINCETON, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a…

OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced its financial results for the…

EXTON, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA)…

– Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced HER2 positive gastric and gastroesophageal…

SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology…

CANTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing…

CAMBRIDGE, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular…

NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset…

WALTHAM, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on…